Skip to main content
. 2020 Jul 13;52(3):410–414. doi: 10.3947/ic.2020.52.3.410

Figure 1. Clinical course, drug administration, and platelet count of a patient with COVID-19.

Figure 1

A 54-year-old Korean male patient with COVID-19 experienced severe thrombocytopenia with epistaxis and petechiae. Platelet count dropped to 2,000/mm3 while receiving ceftriaxone, levofloxacin, and Lopinavir/ritonavir, while it recovered soon after discontinuation of all the suspected drugs.

COVID-19, coronavirus disease 2019; HCQ, hydroxychloroquine; PC, platelet concentrate; Sx, symptom; NP, nasal prong; CXR, Chest X-ray; RLL, right lower lobe.